Patents by Inventor H. Ralph Snodgrass

H. Ralph Snodgrass has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC USES OF L-4-CHLOROKYNURENINE
    Publication number: 20240122887
    Abstract: Pharmaceutical compositions comprising L-4-chlorokynurenine and associated therapeutic methods are provided for the treatment of certain neurological and other conditions.
    Type: Application
    Filed: September 30, 2022
    Publication date: April 18, 2024
    Applicant: VISTAGEN THERAPEUTICS, INC.
    Inventor: H. Ralph SNODGRASS
  • DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLOROKYNURENINE
    Publication number: 20220409564
    Abstract: Compositions of L-4-chlorokynurenine are provided, as are methods for the treatment of neurological dysfunction.
    Type: Application
    Filed: June 21, 2022
    Publication date: December 29, 2022
    Applicant: VISTAGEN THERAPUETICS, INC.
    Inventors: H. Ralph SNODGRASS, Allen E. CATO, Jack S. HICKLIN
  • Dosage forms and therapeutic uses of L-4-chlorokynurenine
    Patent number: 10980758
    Abstract: Compositions of L-4-chlorokynurenic are provided, as are methods for the treatment of neurological dysfunction.
    Type: Grant
    Filed: June 8, 2018
    Date of Patent: April 20, 2021
    Assignee: VISTAGEN THERAPEUTICS, INC.
    Inventors: H. Ralph Snodgrass, Allen E. Cato, Jack S. Hicklin
  • Dosage forms and therapeutic uses of L-4-chlorokynurenine
    Patent number: 10821089
    Abstract: Compositions of L-4-chlorokynurenic are provided, as are methods for the treatment of neurological dysfunction.
    Type: Grant
    Filed: June 8, 2018
    Date of Patent: November 3, 2020
    Assignee: VISTAGEN THERAPEUTICS, INC.
    Inventors: H. Ralph Snodgrass, Allen E. Cato, Jack S. Hicklin
  • Dosage forms and therapeutic uses of L-4-chlorokynurenine
    Patent number: 10632091
    Abstract: Compositions of L-4-chlorokynurenine are provided, as are methods for the treatment of neurologica dyslinction.
    Type: Grant
    Filed: May 14, 2018
    Date of Patent: April 28, 2020
    Assignee: VISTAGEN THERAPEUTICS, INC.
    Inventors: H. Ralph Snodgrass, Allen E. Cato, Jack S. Hicklin
  • Dosage forms and therapeutic uses of L-4-chlorokynurenine
    Patent number: 10617663
    Abstract: Compositions of L-4-chlorokynurenine are provided, as are methods for the treatment of neurological dysfunction.
    Type: Grant
    Filed: June 8, 2018
    Date of Patent: April 14, 2020
    Assignee: VISTAGEN THERAPEUTICS, INC.
    Inventors: H. Ralph Snodgrass, Allen E. Cato, Jack S. Hicklin
  • THERAPEUTIC USES OF L-4-CHLOROKYNURENINE
    Publication number: 20190321317
    Abstract: Pharmaceutical compositions comprising L-4-chlorokynurenine and associated therapeutic methods are provided for the treatment of certain neurological and other conditions.
    Type: Application
    Filed: May 6, 2019
    Publication date: October 24, 2019
    Applicant: VISTAGEN THERAPEUTICS, INC.
    Inventor: H. Ralph SNODGRASS
  • DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLOROKYNURENINE
    Publication number: 20190133984
    Abstract: Compositions of L-4-chlorokynurenic are provided, as are methods for the treatment of neurological dysfunction.
    Type: Application
    Filed: June 8, 2018
    Publication date: May 9, 2019
    Applicant: VISTAGEN THERAPUETICS, INC.
    Inventors: H. Ralph SNODGRASS, Allen E. CATO, Jack S. HICKLIN
  • DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLOROKYNURENINE
    Publication number: 20190125707
    Abstract: Compositions of L-4-chlorokynurenine are provided, as are methods for the treatment of neurologica dyslinction.
    Type: Application
    Filed: May 14, 2018
    Publication date: May 2, 2019
    Applicant: VISTAGEN THERAPEUTICS, INC.
    Inventors: H. Ralph SNODGRASS, Allen E. CATO, Jack S. HICKLIN
  • DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLOROKYNURENINE
    Publication number: 20180369180
    Abstract: Compositions of L-4-chlorokynurenine are provided, as are methods for the treatment of neurological dysfunction
    Type: Application
    Filed: June 8, 2018
    Publication date: December 27, 2018
    Applicant: VISTAGEN THERAPUETICS, INC.
    Inventors: H. Ralph SNODGRASS, Allen E. CATO, Jack S. HICKLIN
  • DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLOROKYNURENINE
    Publication number: 20180289649
    Abstract: Compositions of L-4-chlorokynurenine are provided, as are methods for the treatment of neurological dysfunction.
    Type: Application
    Filed: June 8, 2018
    Publication date: October 11, 2018
    Applicant: VISTAGEN THERAPUETICS, INC.
    Inventors: H. Ralph SNODGRASS, Allen E. CATO, Jack S. HICKLIN
  • Dosage forms and therapeutic uses L-4-chlorokynurenine
    Patent number: 9993453
    Abstract: Compositions of L-4-chlorokynurenine are provided, as are methods for the treatment of neurological dysfunction.
    Type: Grant
    Filed: February 8, 2016
    Date of Patent: June 12, 2018
    Assignee: VISTAGEN THERAPEUTICS, INC.
    Inventors: H. Ralph Snodgrass, Allen E. Cato, Jack S. Hicklin
  • Dosage forms and therapeutic uses of L-4-chlorokynurenine
    Patent number: 9993450
    Abstract: Compositions of L-4-chlorokynurenine are provided, as are methods for the treatment of neurological dysfunction.
    Type: Grant
    Filed: January 22, 2014
    Date of Patent: June 12, 2018
    Assignee: VISTAGEN THERAPEUTICS, INC.
    Inventors: H. Ralph Snodgrass, Allen E. Cato, Jack S. Hicklin
  • THERAPEUTIC USES OF L-4-CHLOROKYNURENINE
    Publication number: 20180140568
    Abstract: Pharmaceutical compositions comprising L-4-chlorokynurenine and associated therapeutic methods are provided for the treatment of certain neurological and other conditions.
    Type: Application
    Filed: May 23, 2016
    Publication date: May 24, 2018
    Inventors: H. Ralph SNODGRASS, Allen E. CATO, Jack S. HICKLIN
  • DOSAGE FORMS AND THERAPEUTIC USES L-4-CHLOROKYNURENINE
    Publication number: 20160158178
    Abstract: Compositions of L-4-chlorokynurenine are provided, as are methods for the treatment of neurological dysfunction.
    Type: Application
    Filed: February 8, 2016
    Publication date: June 9, 2016
    Applicant: VISTAGEN THERAPEUTICS, INC.
    Inventors: H. Ralph SNODGRASS, Allen E. CATO, Jack S. HICKLIN
  • DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLOROKYNURENINE
    Publication number: 20150359772
    Abstract: Compositions of L-4-chlorokynurenine are provided, as are methods for the treatment of neurological dysfunction.
    Type: Application
    Filed: January 22, 2014
    Publication date: December 17, 2015
    Inventors: H. Ralph SNODGRASS, Allen E. CATO, Jack S. HICKLIN
  • Toxicity typing using liver stem cells
    Patent number: 8512957
    Abstract: This invention provides methods and systems for identifying and typing toxicity of chemical compositions, as well as for screening new compositions for toxicity. The invention involves detecting alterations in gene or protein expression and hence establishing molecular profiles in isolated mammalian LSCs contacted with various chemical compositions of known and unknown toxicities, and correlating the molecular profiles with toxicities of the chemical compositions.
    Type: Grant
    Filed: February 21, 2012
    Date of Patent: August 20, 2013
    Assignee: Vistagen Therapeutics, Inc.
    Inventor: H. Ralph Snodgrass
  • TOXICITY TYPING USING LIVER STEM CELLS
    Publication number: 20120220469
    Abstract: This invention provides methods and systems for identifying and typing toxicity of chemical compositions, as well as for screening new compositions for toxicity. The invention involves detecting alterations in gene or protein expression and hence establishing molecular profiles in isolated mammalian LSCs contacted with various chemical compositions of known and unknown toxicities, and correlating the molecular profiles with toxicities of the chemical compositions.
    Type: Application
    Filed: February 21, 2012
    Publication date: August 30, 2012
    Applicant: VistaGen Therapeutics, Inc.
    Inventor: H. Ralph SNODGRASS
  • Toxicity typing using liver stem cells
    Patent number: 8143009
    Abstract: This invention provides methods and systems for identifying and typing toxicity of chemical compositions, as well as for screening new compositions for toxicity. The invention involves detecting alterations in gene or protein expression and hence establishing molecular profiles in isolated mammalian LSCs contacted with various chemical compositions of known and unknown toxicities, and correlating the molecular profiles with toxicities of the chemical compositions.
    Type: Grant
    Filed: June 1, 2006
    Date of Patent: March 27, 2012
    Assignee: VistaGen, Inc.
    Inventor: H. Ralph Snodgrass
  • PANCREATIC ENDOCRINE PROGENITOR CELLS DERIVED FROM PLURIPOTENT STEM CELLS
    Publication number: 20090280096
    Abstract: The invention provides pluripotent cells modified to overexpress Pdx1 and Ngn3. Pluripotent cells include embryonic stem cells and induced pluripotent stem cells. Methods of producing pancreatic endocrine progenitor cells from ES cells or from iPS cells by forced expression of Pdx1 and Ngn3 are provided. Pancreatic endocrine progenitor cells are useful for drug discovery and cell replacement therapy.
    Type: Application
    Filed: May 11, 2009
    Publication date: November 12, 2009
    Inventors: Atsushi KUBO, Kristina Bonham, Robert Stull, H. Ralph Snodgrass